SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-041053
Filing Date
2023-07-05
Accepted
2023-07-05 16:22:14
Documents
2
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1647
2 POA DOCUMENT poa.txt EX-24 3964
  Complete submission text file 0001209191-23-041053.txt   7250
Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
Lurier Eliot M (Reporting) CIK: 0001438037 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37939 | Film No.: 231069355